General Information of This Drug (ID: DMCR1MV)

Drug Name
Itraconazole   DMCR1MV
Synonyms
Canadiol; Hyphanox; ITCZ; ITZ; Intraconazole; Itraconazol; Itraconazolum; Itrizole; Oriconazole; Orungal; Prokanazol; Sempera; Spherazole; Sporal; Sporanos; Sporanox; Sporonox; Triasporn; Itraconazol [Spanish]; Itraconazole oral solution; Itraconazolum [Latin]; R 51211; Cis-Itraconazole; Itraconazole & Bovine Lactoferrin; Itraconazole & Nyotran; Itrizole (TN); R-51211; Sporanox (TN); Itraconazole & Nyotran(Liposomal Nystatin); Itraconazole (JAN/USAN); Oriconazole, R51211, Sporanox; Itraconazole [USAN:BAN:INN:JAN]; (+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one; (1)-cis-4-(4-(4-(4-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2,4-dihydro-2-sec-butyl-3H-1,2,4-triazol-3-one; 2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one; 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one; 2-butan-2-yl-4-[4-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one; 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one; 3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-pipera-zinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl); 4-(4-{4-[4-({[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}oxy)phenyl]piperazin-1-yl}phenyl)-2-(1-methylpropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
Indication
Disease Entry ICD 11 Status REF
Aspergillosis 1F20 Approved [1]
Blastomycosis 1F22 Approved [1]
Fungal infection 1F29-1F2F Approved [2]
Fusariosis N.A. Approved [1]
Histoplasmosis N.A. Approved [1]
Invasive candidiasis 1F23 Approved [1]
Mycoses 1F2Z Approved [1]
Candidemia 1F23.3Y Investigative [1]
Esophageal candidiasis N.A. Investigative [1]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Antifungal Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

78 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole + Itraconazole DCNQ5DC 1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Amiloride + Itraconazole DCL0HWQ Amiloride Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Arfolitixorin + Itraconazole DCNBTUB Arfolitixorin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
BIO-300 + Itraconazole DCKPDTV BIO-300 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Brincidofovir + Itraconazole DCOTVOR Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Carglumic acid + Itraconazole DCZORZS Carglumic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Cerivastatin + Itraconazole DCO1OON Cerivastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Cilostazol + Itraconazole DC4XDZ8 Cilostazol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Clopidogrel + Itraconazole DCCVCJ9 Clopidogrel Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Desoxycorticosterone pivalate + Itraconazole DCLEMOM Desoxycorticosterone pivalate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Diphenidol + Itraconazole DCEXZZE Diphenidol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Everolimus + Itraconazole DCS6I8C Everolimus Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Fomepizole + Itraconazole DC0UU8T Fomepizole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
GINKGOLIDE A + Itraconazole DCBELAY GINKGOLIDE A Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
GYKI-52466 + Itraconazole DCZ0P4D GYKI-52466 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Meclofenamic acid DCNKCYF Meclofenamic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Lefaxin DCFTPZ9 Lefaxin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Sertraline DCUK556 Sertraline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Mebutamate DC16WOF Mebutamate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Bepridil DCIRWKS Bepridil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Clindamycin DCRL3XB Clindamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Dantrolene DCPXO03 Dantrolene Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Diethylcarbamazine DC1DYPT Diethylcarbamazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Ruxolitinib DCCOP01 Ruxolitinib T-cell leukemia/lymphoma (Cell Line: ED-40515) [3]
Itraconazole + Anamorelin DC3Z5BB Anamorelin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Triapine DCYOGN3 Triapine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Rifampin DC4571C Rifampin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + IT-141 DCP7TU3 IT-141 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Isosorbide dinitrate DCUHLZH Isosorbide dinitrate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Memantine DC5JWUU Memantine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Methoxsalen DCPH593 Methoxsalen Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Galantamine DCJZDG0 Galantamine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + PF-02545920 DCQZDAW PF-02545920 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Tiagabine DCBC83I Tiagabine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Pargyline DCM2TWG Pargyline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Idarubicin DC3AO83 Idarubicin Glioblastoma? (Cell Line: T98G) [3]
Itraconazole + Imatinib DCH297L Imatinib Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Bortezomib DC84RIN Bortezomib Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Moricizine DCI2ZHU Moricizine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Clascoterone DC6QV2N Clascoterone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Maprotiline DCO0S4U Maprotiline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Eptifibatide DC6UV0B Eptifibatide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Chlorambucil DCYKG6G Chlorambucil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Acarbose DCJ7EO0 Acarbose Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Brincidofovir DCC8LM4 Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Sorafenib DC800LF Sorafenib Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Chloroquine DCSGB6K Chloroquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Quinine DCVT685 Quinine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Mycophenolic acid DC3BJV6 Mycophenolic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Doxorubicin DCOHRE8 Doxorubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + ML323 DCN9KN4 ML323 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Enoxacin DCGAQ2A Enoxacin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Azatadine DCEFJYE Azatadine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Itraconazole + Cytarabine DCTJGQ7 Cytarabine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Kanamycin + Itraconazole DCJ3NLI Kanamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Leflunomide + Itraconazole DCL5AXH Leflunomide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Levamisole + Itraconazole DC6Y9RS Levamisole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Lubiprostone + Itraconazole DC3PC3O Lubiprostone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Mebendazole + Itraconazole DC847E7 Mebendazole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Methylene blue + Itraconazole DC9R94I Methylene blue Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Oxandrolone + Itraconazole DC7XYRX Oxandrolone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pepstatin + Itraconazole DC84F4M Pepstatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Phensuximide + Itraconazole DCHX6UV Phensuximide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Picoplatin + Itraconazole DCE83Z6 Picoplatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pinacidil + Itraconazole DC29K6P Pinacidil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pizotyline + Itraconazole DCU5ANF Pizotyline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
PMID28870136-Compound-43 + Itraconazole DCZL11P PMID28870136-Compound-43 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tacrine + Itraconazole DCWD30E Tacrine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Testosterone + Itraconazole DCD0G67 Testosterone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tolazoline + Itraconazole DC5FMR2 Tolazoline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tolvaptan + Itraconazole DCUS7NH Tolvaptan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Trifluoperazine + Itraconazole DCRQ5W8 Trifluoperazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Triflupromazine + Itraconazole DC40T5G Triflupromazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Trioxsalen + Itraconazole DCDXWDO Trioxsalen Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Ursodeoxycholic acid + Itraconazole DCR5LSF Ursodeoxycholic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Itraconazole DCN8WJC Vinblastine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vorinostat + Itraconazole DCKKWN1 Vorinostat Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Zaleplon + Itraconazole DCHNROA Zaleplon Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 78 DrugCom(s)
27 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Esomeprazole + Itraconazole DCRW12B Esomeprazole Achlorhydria [4]
Itraconazole + Midostaurin DC69NA5 Midostaurin Acute Myeloid Leukemia [5]
Itraconazole + Pemetrexed DCRSO9C Pemetrexed Recurrent Non Small Cell Lung Cancer [6]
Itraconazole + Hydroxychloroquine DC273GQ Hydroxychloroquine Platinum-resistant Epithelial Ovarian Cancer [7]
Itraconazole + Risdiplam DC2TBRF Risdiplam Spinal Muscular Atrophy [8]
Itraconazole + Mifepristone DC5W95F Mifepristone Drug Interaction Potentiation [9]
Itraconazole + Ecopipam DCIZNOY Ecopipam Drug Interaction [10]
Itraconazole + KAF156 DCMXVCB KAF156 Malaria [11]
Itraconazole + MLN8237 DCOHHDZ MLN8237 Advanced Solid Tumors [12]
Itraconazole + Ritonavir DCPNBQ9 Ritonavir HER2-positive Advanced Solid Tumor [13]
Itraconazole + Fluconazole DCQDFVA Fluconazole Tinea Versicolor [14]
Itraconazole + Bay 80-6946 DCQHHEM Bay 80-6946 Medical Oncology [15]
Itraconazole + Fruquintinib DCT8F95 Fruquintinib Drug Drug Interaction [16]
Itraconazole + Relugolix DCTCVPY Relugolix Prostate Cancer [17]
Itraconazole + CC-220 DCV7DHT CC-220 Pharmacokinetics [18]
Itraconazole + Tazemetostat DCWVYM0 Tazemetostat All Malignancies [19]
Itraconazole + BAY 10-00394 DCXUGNE BAY 10-00394 Medical Oncology [20]
Lumacaftor + Itraconazole DCTURSU Lumacaftor Cystic Fibrosis [21]
MK-1775 + Itraconazole DC0DPZ7 MK-1775 Advanced Solid Tumours [22]
Rilapladib + Itraconazole DCQ3ZVG Rilapladib Alzheimer's Disease [23]
Savolitinib + Itraconazole DCX85H4 Savolitinib Solid Tumour [24]
Talazoparib + Itraconazole DCDSWL6 Talazoparib Advanced Solid Tumors [25]
Tesetaxel + Itraconazole DCME3T7 Tesetaxel Advanced Solid Tumors [26]
Tucatinib + Itraconazole DCX8YWU Tucatinib Drug-drug Interaction [27]
Isotretinoin + Itraconazole DCCXGFS Isotretinoin Tinea [28]
Itraconazole + Terbinafine DCO58NW Terbinafine Tinea Corporis [29]
Itraconazole + Prednisolone DC0XWW6 Prednisolone Allergic Bronchopulmonary Aspergillosis [30]
------------------------------------------------------------------------------------
⏷ Show the Full List of 27 DrugCom(s)

References

1 Itraconazole FDA Label
2 FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 076104.
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 ClinicalTrials.gov (NCT04942652) Study to Evaluate Effects of Food or Proton Pump Inhibitor on the Pharmacokinetics of Itraconazole in Healthy Volunteers
5 ClinicalTrials.gov (NCT00045942) PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)
6 ClinicalTrials.gov (NCT00769600) Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC
7 ClinicalTrials.gov (NCT03081702) A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer
8 ClinicalTrials.gov (NCT02633709) A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) Given by Mouth in Healthy Volunteers
9 ClinicalTrials.gov (NCT03259542) Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor
10 ClinicalTrials.gov (NCT06194864) Drug Interaction Study
11 ClinicalTrials.gov (NCT05084651) Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Itraconazole
12 ClinicalTrials.gov (NCT02259010) A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma
13 ClinicalTrials.gov (NCT05150691) A Study of DB-1303 in Advanced/Metastatic Solid Tumors
14 ClinicalTrials.gov (NCT05862714) Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Patients With Pityriasis Versicolor
15 ClinicalTrials.gov (NCT02253420) COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients
16 ClinicalTrials.gov (NCT04557397) Fruquintinib CYP3A Inhibitor and Inducer Study
17 ClinicalTrials.gov (NCT05679388) A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients
18 ClinicalTrials.gov (NCT02820935) Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects
19 ClinicalTrials.gov (NCT04537715) Study to Describe the Interaction Between Tazemetostat and Itraconazole and Between Tazemetostat and Rifampin in Participants With Advanced Cancer
20 ClinicalTrials.gov (NCT02457351) Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study
21 ClinicalTrials.gov (NCT01768663) A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects
22 ClinicalTrials.gov (NCT04959266) A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib
23 ClinicalTrials.gov (NCT02130661) Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers
24 ClinicalTrials.gov (NCT04121910) A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole
25 ClinicalTrials.gov (NCT03077607) A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors
26 ClinicalTrials.gov (NCT04312282) The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors
27 ClinicalTrials.gov (NCT03723395) A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib
28 ClinicalTrials.gov (NCT03471455) Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis
29 ClinicalTrials.gov (NCT05881980) Efficacy and Safety of Terbinafine and Itraconazole
30 ClinicalTrials.gov (NCT06174922) A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis